COMP <GO>
AHR vs MS // REVENUE GROWTH (YOY)
American Healthcare REIT Inc. (NYSE) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: AHR 8
— MS 7
▲ REVENUE GROWTH (YOY) LEADER: AHR
LAST: $53.52 (+1.10%) • MKT CAP: $12.34B
revenue-growth
11.20%
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
revenue-growth
5.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHR VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AHR | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 14.40% | 41.00% | -26.60 | MS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.10% | 3.00% | +5.10 | AHR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.4x | 31.0x | -4.60 | AHR | /valuation <GO> |
| Free Cash Flow Yield | 1.62% | -7.25% | +8.87 | AHR | /fcf-yield <GO> |
| Operating Margin | 19.80% | 24.60% | -4.80 | MS | /operating-margins <GO> |
| Net Profit Margin | 3.40% | 20.20% | -16.80 | MS | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 11.20% | 5.50% | +5.70 | AHR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.32% | 2.21% | -0.89 | MS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.12 | 0.46 | +3.66 | AHR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | AHR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 7.00% | +0.30 | MS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.6 | 43.3 | +11.35 | AHR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 1.04 | +0.07 | AHR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 16.5x | +123.50 | MS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.34B | $298.41B | -$286.06B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AHR REV | MS REV | AHR GROSS % | MS GROSS % | AHR FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.09B | $0 | 14.4% | — | $200.2M | -$17.89B |
| FY 2024 | $1.88B | $0 | 12.2% | — | $91.3M | $1.36B |
| FY 2023 | $1.67B | $0 | 44.0% | — | $23.4M | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHR // BETA 1.11
MS // BETA 1.04